Accepted but Unacceptable: Peripheral IV Catheter Failure

Journal of Infusion Nursing

Volumn 38, Issue 3, 2015, Pages 189-203

  Helm, Robert E ^a   Klausner, Jeffrey D ^b   Klemperer, John D ^a   Flint, Lori M ^c   Huang, Emily ^c  

^a Portsmouth Regional Hospital   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EASTERN MAINE MEDICAL CENTER   (United States)

Author keywords

bloodstream infection; dislodgment; infiltration; occlusion; peripheral intravenous catheter failure; phlebitis

Indexed keywords

ARTICLE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CATHETER COMPLICATION; CATHETER DISLODGMENT; CATHETER INFECTION; CATHETER INFILTRATION; CATHETER OCCLUSION; CATHETER REMOVAL; COST OF ILLNESS; ENTEROCOCCUS; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PERIPHERAL VENOUS CATHETER; PHLEBITIS; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TREATMENT DURATION; VEIN CATHETERIZATION; ADVERSE EFFECTS; CATHETERIZATION; ECONOMICS; NURSING; RISK FACTOR; TIME FACTOR; TREATMENT FAILURE;

CATHETERIZATION, PERIPHERAL; HUMANS; RISK FACTORS; TIME FACTORS; TREATMENT FAILURE;

EID: 84944204888     PISSN: 15331458     EISSN: 15390667     Source Type: Journal    
DOI: 10.1097/NAN.0000000000000100     Document Type: Article

References (164)

1. Dudrick SJ. History of vascular access. J Parenter Enteral Nutr. 2006; 30 (suppl 1): S47-S56.
2. Meyers L. Intravenous catheterization. Am J Nurs. 1945; 45 (11): 930-931.
3. Zimmermann B. Intravenous tubing for parenteral therapy. Science. 1945; 101 (2631): 567-568.
4. Duffy BJ. The clinical use of polyethylene tubing for intravenous therapy. Ann Surg. 1949; 130 (5): 930-936.
5. Massa DJ. A plastic needle. Anesthesiology. 1951; 12 (6): 772-773.
6. Rivera AM, Strauss KW, van Zundert A, Mortier E. The history of peripheral intravenous catheters: how little plastic tubes revolutionized medicine. Act Anaesthesiol Belg. 2005; 56 (3): 271-282.
7. Rickard CM, Webster J, Wallis MC. Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomized controlled equivalence trial. Lancet. 2012; 380 (9847): 1066-1074.
8. Higa LS. IV catheters. Infect Control Today. 2000; 3 (6). http://www.infectioncontroltoday.com/articles/2000/06/iv-catheters. aspx. Accessed December 18, 2014.
9. Morris W, Tay MH. Strategies for preventing peripheral intravenous cannula infection. Br J Nurs. 2008; 17 (19): S14-S21.
10. Zingg W, Pittet D. Peripheral venous catheters: an under-evaluated problem. Int J Antimicrob Agents. 2009; 34 (suppl 4): S38-S42.
11. Corrigan A. Infusion nursing as a specialty. In: Alexander M, Corrigan A, Gorski L, Hankins J, Perucca R, eds. Infusion Nursing: An Evidence-Based Approach. 3rd ed. St Louis, MO: Saunders/Elsevier; 2010: 1-9.
12. Hadaway L. Short peripheral IV catheters and infections. J Infus Nurs. 2012; 35 (4): 230-240.
13. M. Peripheral intravenous catheter complication rate comparison of two different catheter-stabilization systems (PIV secural). ClinicalTrials.gov. US National Institutes of Health. http://clini caltrials.gov/ct2/show/NCT01382524. NLM Identifier: NCT01382524. Accessed December 19, 2014.
14. Maki DG. Improving the safety of peripheral intravenous catheters . BMJ. 2008; 337: 122-123.
15. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006; 81 (9): 1159-1171.
16. Moureau NL. IV rounds: reducing the cost of catheter-related bloodstream infections. Nursing. 2012; 39 (7): 14-15.
17. Sabri A, Szalas J, Holmes KS, Labib L, Mussivand T. Failed attempts and improvement strategies in peripheral intravenous catheterization. Biomed Mater Eng. 2013; 23 (1-2): 93-108.
18. Idata Research Group. US market for vascular access devices and accessories. Vancouver, BC: iData; 2008.
19. Webster J, Clarke S, Paterson D, et al. Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial. BMJ. 2008; 337: 1-6.
20. Bausone-Gazda D, Lefavier CA, Walters SA. A randomized controlled trial to compare the complications of 2 peripheral intravenous stabilization systems. J Infus Nurs. 2010; 33 (6): 371-384.
21. Martínez JA, Piazuelo M, Almela M, et al. Evaluation of add-on devices for the prevention of phlebitis and other complications associated with the use of peripheral catheters in hospitalised adults: a randomised controlled study. J Hosp Infect. 2009; 73 (2): 135-142.
22. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR. www.cdc.gov/hicpac/BSI/BSI-guidelines-2011.html. Accessed March 10, 2015.
23. Scales K. Intravenous therapy: a guide to good practice. Br J Nurs. 2008; 17 (19): S4-S12.
24. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs. 2011; 34 (suppl 1): S1-S110.
25. Royal College of Nursing. Standards for Infusion Therapy: The RCN IV Therapy Forum. 3rd ed. London, UK: Royal College of Nursing; 2010. http://www.bbraun.it/documents/RCN-Guidlinesfor-IV-therapy.pdf. Accessed December 19, 2014.
26. Hawes ML. A proactive approach to combating venous depletion in the hospital setting. J Infus Nurs. 2007; 30 (1): 33-44.
27. Smith JP. Thrombotic complications in intravenous access. J Intraven Nurs. 1998; 21 (2): 96-100.
28. Greig JM, Ellis CJ, Smith EG. Septic discitis and other complications of peripheral venous cannulation. QJM. 2002; 95 (6): 412-413.
29. Doellman D, Hadaway L, Bowe-Geddes LA, et al. Infiltration and extravasation: update on prevention and management. J Infus Nurs. 2009; 32 (4): 203-211.
30. Hollenbeak CS. The cost of catheter-related bloodstream infections . J Infus Nurs. 2012; 34 (5): 309-313.
31. Martin SM. Extravasation management of nonchemotherapeutic medications. J Infus Nurs. 2013; 36 (6): 392-396.
32. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2007; 355 (26): 2725-2732.
33. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007; 7 (10): 645-657.
34. Centers for Disease Control and Prevention. Vital signs: carbapenem-resistant enterobacteriaceae. MMWR Morb Mortal Wkly Rep. 2013; 62 (9): 165-170. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6209a3.htm?s-cid = mm6209a3-w. Accessed December 19, 2014.
35. Abad CL, Safdar N. Catheter-related bloodstream infections. Infect Dis Special Edit. 2011;14: 84-98.
36. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004; 39 (3): 309-317.
37. Centers for Disease Control and Prevention. Guidance for Control of Carbapenem-Resistant Enterobacteriaceae (CRE). 2012 CRE Toolkit. Atlanta, GA: Centers for Disease Control and Prevention; 2012. www.cdc.gov/hai/pdfs/cre/CRE-guidance-508. pdf. Accessed December 19, 2014.
38. Marquez P, Terashita D. Editorial commentary: long-term acute care hospitals and carbapenem-resistant Enterobacteriaceae: a reservoir for transmission. Clin Inf Dis. 2013; 57 (9): 1253-1255.
39. Haas LEM, Kortlandt BC, Thijsen SFT, Fijen JW, Sankatsing SUC. A fatal complication of a peripheral venous catheter. Int J Clin Med. 2012; 3: 433-437.
40. Liau DW. Injuries and liability related to peripheral catheters: a closed claims analysis. ASA Newsletter. 2006; 70 (6): 11-13, 16.
41. Kagel EM, Rayan GM. Intravenous complications in the hand and forearm. J Trauma. 2004; 56 (1): 123-127.
42. Zhang L, Keogh S, Rickard CM. Reducing the risk of infection associated with vascular access devices through nanotechnology: a perspective. Int J Nanomedicine. 2013; 8: 4453-4466.
43. Carlquist K. Understanding the psychological needs of the patient on IV therapy: a stress-reducing approach. NITA. 1981; 4 (5): 368-370.
44. Burnett E, Lee K, Rushmer R, Ellis M, Noble M, Davey P. Healthcare associated infection and the patient experience: a qualitative study using patient interviews. J Hosp Infect. 2010; 74 (1): 42-47.
45. Malach T, Jerassy Z, Rudensky B, et al. Prospective surveillance of phlebitis associated with peripheral intravenous catheters. Am J Infect Control. 2006; 34 (5): 308-312.
46. Powell J, Tarnow KG, Perucca R. The relationship between peripheral intravenous catheter indwell time and the incidence of phlebitis. J Infus Nurs. 2008; 31 (1): 39-45.
47. Gillies D, O'Riordan E. Should intravenous catheters be replaced routinely? Lancet. 2012; 380 (9847): 1036-1038.
48. Idvall E, Gunningberg L. Evidence for elective replacement of peripheral intravenous catheters to prevent thrombophlebitis: a systematic review. J Adv Nurs. 2006; 55 (6): 715-722.
49. Ho KH, Cheung DS. Guidelines on timing in replacing peripheral intravenous catheters. J Clin Nurs. 2012; 21 (11-12): 1499-1506.
50. Webster J, Osborne S, Rickard C, Hall J. Clinically indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2010;(3): CD007798.
51. Rickard CM, McCann D, Munnings J, McGrail MR. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Med. 2010; 8 (53): 1-10.
52. Schears GJ. Summary of product trials for 10,164 patients: comparing an intravenous stabilizing device to tape. J Infus Nurs. 2006; 29 (4): 225-231.
53. Chico-Padrón RM, Carrión-Garciá L, Delle-Vedove-Rosales L, et al. Comparative safety and costs of transparent versus gauze wound dressings in intravenous catheterization. J Nurs Care Qual. 2011; 26 (4): 371-376.
54. Smith B. Peripheral intravenous catheter dwell times: a comparison of 3 securement methods for implementation of a 96-hour scheduled change protocol. J Infus Nurs. 2006; 29 (1): 14-17.
55. Dillon MF, Curran J, Martos R, et al. Factors that affect longevity of intravenous cannulas: a prospective study. QJM. 2008; 101 (9): 731-735.
56. Bolton D. Improving peripheral cannulation practice at an NHS Trust. Br J Nurs. 2010; 19 (21): 1346-1350.
57. Washington GT, Barrett R. Peripheral phlebitis: a point-prevalence study. J Infus Nurs. 2012; 35 (4): 252-258.
58. Dargin JM, Rebholz CM, Lowenstein RA, et al. Ultrasonographyguided peripheral intravenous catheter survival in ED patients with difficult access. Am J Emerg Med. 2010; 28 (1): 1-7.
59. Cashin-Garbutt, A. Intravenous catheter replacement: an interview with Claire Rickard. http://www.news-medical.net/news/20121030/Intravenous-catheter-replacement-an-interview-with-Claire-Rickard.aspx. Published on October 30, 2012.
60. Wallis MC, McGrail M, Webster J, et al. Risk factors for peripheral intravenous catheter failure: a multivariate analysis of data from a randomized controlled trial. Infect Control Hosp Epidemiol. 2014; 35 (1): 63-68.
61. Elia F, Ferrari G, Molino P, et al. Standard-length catheters vs long catheters in ultrasound-guided peripheral vein cannulation. Am J Emerg Med. 2012; 30 (5): 712-716.
62. Panadero A, Iohom G, Taj J, Mackay N, Shorten G. A dedicated intravenous cannula for postoperative use effect on incidence and severity of phlebitis. Anaesthesia. 2002; 57 (9): 921-925.
63. Mestre Roca G, Berbel Bertolo C, Tortajada Lopez P, et al. Assessing the influence of risk factors on rates and dynamics of peripheral vein phlebitis: an observational cohort study. Med Clin (Barc). 2012; 139 (5): 185-191.
64. Salguiero-Oliveira A, Parreira P, Veiga P. Incidence of phlebitis in patients with peripheral intravenous catheters: the influence of some risk factors. Austral J Adv Nurs. 2012; 30 (2): 32-39.
65. Fields JM, Dean AJ, Todman RW, et al. The effect of vessel depth, diameter, and location on ultrasound-guided peripheral intravenous catheter longevity. Am J Emerg Med. 2012; 30 (7): 1134-1140.
66. McNeill E, Hines NL, Phariss R. A clinical trial of a new all-inone peripheral short catheter. JAVA. 2009; 14 (1): 46-51.
67. Gallant P, Schultz AA. Evaluation of a visual infusion phlebitis scale for determining appropriate discontinuation of peripheral intravenous catheters. J Infus Nurs. 2006; 29 (6): 338-342.
68. Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol. 1990; 28 (1): 2520-2525.
69. Ascoli GB, DeGuzman PB, Rowlands A. Peripheral intravenous catheter complication rates between those indwelling > 96 hours to those indwelling 72-96 hours: a retrospective correlational study. Int J Nurs. 2012; 1 (2): 7-12.
70. Jackson A. Retrospective comparative audit of two peripheral IV securement dressings. Br J Nurs. 2012; 21 (suppl 1): S10-S15.
71. Tagalakis V, Kahn SR, Libman M, Blostein M. The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med. 2002; 113 (2): 146-151.
72. Baxter Healthcare. Principles and Practice of IV Therapy. Compton, UK: Baxter Healthcare Ltd; 1998.
73. Pittet D, Chuard C, Rae AC, Auckenthaler R. Clinical diagnosis of central venous catheter line infection: a difficult job. Program and abstracts: 31st Interscience Conference on Antimicrobial Agents and Chemotherapy; September 29-October 2, 1991; Chicago, IL.
74. McCallum L, Higgins D. Care of peripheral venous cannula sites. Nurs Times. 2012; 108 (34-35): 12-15.
75. Uslusoy E, Mete S. Predisposing factors to phlebitis in patients with peripheral venous catheters: a descriptive study. J Am Acad Nurse Pract. 2008; 20 (4): 172-180.
76. Tager IB, Ginsberg MB, Ellis SE, et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol. 1983; 118 (6): 839-851.
77. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med. 1998; 158 (5): 473-477.
78. Da Silva Almendra P, Mohallem A, Moura D, et al. Incidence of phlebitis in patients receiving antibiotics therapy through peripheral intravenous catheters: a safety cluster-randomized pilot trial. Abstracts of the Critical Care Canada Forum; 2013; Toronto, Canada.
79. Tripathi S, Kaushik V, Singh V. Peripheral IVs: factors affecting complications and patency-a randomized controlled trial. J Infus Nurs. 2008; 31 (3): 182-188.
80. Haddad FG, Waked CH, Zein EF. Peripheral venous catheterrelated inflammation: a randomized prospective trial. J Med Liban. 2006; 54 (3): 139-145.
81. Bertolino G, Pitassi A, Tinelli C, et al. Intermittent flushing with heparin versus saline for maintenance of peripheral intravenous catheters in a medical department: a pragmatic cluster-randomized controlled study. Worldviews Evidence Based Nurs. 2012; 9 (4): 221-226.
82. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral catheters: a randomized controlled trial. Ann Intern Med. 1991; 114 (10): 845-854.
83. White SA. Peripheral intravenous therapy-related phlebitis rates in an adult population. J Intraven Nurs. 2001; 24 (1): 19-24.
84. Lee WL, Chen HL, Tsai TY, et al. Risk factors for peripheral intravenous catheter infection in hospitalized patients: a prospective study of 3165 patients. Am J Infect Control. 2009; 37 (8): 683-686.
85. Bonnici ET. Safer patient care through better peripheral intravenous catheter management. Int J Infect Control. 2012; 8 (2): 1-7.
86. Tomford JW, Hershey CO, McLaren CE, Porter DK, Cohen DI. Intravenous therapy team and peripheral venous catheter associated complications: a prospective controlled study. Arch Intern Med. 1984; 144 (6): 1191-1194.
87. Campbell L. IV-related phlebitis, complications and length of hospital stay. Br J Nurs. 1998; 7 (22): 1364-1366.
88. Grune F, Schrappe M, Basten J, et al. Phlebitis rate and time kinetics of short peripheral intravenous catheters. Infection. 2004; 32 (1): 30-32.
89. Saini R, Agnihotri M, Gupta A, Walia I. Epidemiology of infiltration and phlebitis. Nurs Midwifery Res J. 2011; 7 (1): 22-33.
90. Sarafzadeh F, Gholamreza S, Yazdizadeh M. Evaluation of the severity of peripheral intravenous catheter related phlebitis during one year in an Iranian educational hospital, Kerman, Iran. Ann Biol Res. 2012; 3 (10): 4741-4746.
91. Do Rego Furtado LC. Maintenance of peripheral venous access and its impact on the development of phlebitis: a survey of 186 catheters in a general surgery department in Portugal. J Infus Nurs. 2011; 34 (6): 382-390.
92. Kaur P, Thakur R, Kaur S, Bhalla A. Assessment of risk factors of phlebitis amongst intravenous cannulated patients. Nurs Midwifery Res J. 2011; 7 (3): 106-114.
93. Singh R, Bhandary S, Pun KD. Peripheral intravenous catheter related phlebitis and its contributing factors among adult population at KU teaching hospital. Kathmandu Univ Med J (KUMJ). 2008; 6 (24): 443-447.
94. Catney MR, Hillis S, Wakefield B, et al. Relationship between peripheral intravenous catheter dwell time and the development of phlebitis and infiltration. J Infus Nurs. 2001; 24 (5): 332-341.
95. Hadaway L. Infiltration and extravasation: preventing a complication of IV catheterization. Am J Nurs. 2007; 107 (8): 64-72.
96. Rego Furtado LC. Incidence and predisposing factors of phlebitis in a surgery department. Br J Nurs. 2011; 20 (14): 30-36.
97. Dychter SS, Gold DA, Carson D, Haller M. Intravenous therapy: a review of complications and economic considerations of peripheral access. J Infus Nurs. 2012; 35 (2): 84-91.
98. Russell PB, Kline J, Yoder MC, Polin RA. Staphylococcal adherence to polyvinyl chloride and heparin-bonded polyurethane catheters is species dependent and enhanced by fibronectin. J Clin Microbiol. 1987; 25 (6): 1083-1087.
99. Treter J, Macedo AJ. Catheters: a suitable surface for biofilm formation. In: Mendez-Vilas A, ed. Science Against Microbial Pathogens: Communicating Current Research and Technological Advances. Badajoz, Spain: Formatex; 2011: 835-842.
100. BioFlo Port [product brochure]. Latham, NY: AngioDynamics; 2014.
101. Wood D. A comparative study of two securement techniques for short peripheral intravenous catheters. J Intraven Nurs. 1997; 20 (6): 280-285.
102. Sheppard K, LeDesma M, Morris NL, O'Connor K. A prospective study of two intravenous catheter securement techniques in a skilled nursing facility. J Intraven Nurs. 1999; 22 (3): 151-156.
103. LaRue GD, Peterson M. The impact of dilution on intravenous therapy. J Infus Nurs. 2011; 34 (2): 117-123.
104. Roszell S, Jones C. Intravenous administration issues: a comparison of intravenous insertions and complications in vancomycin versus other antibiotics. J Infus Nurs. 2010; 33 (2): 112-118.
105. Creamer E, McCarthy G, Tighe I, Smythe E. A survey of 554 peripheral intravenous catheters: infection, duration of cannulation and documentation issues. Br J Infect Control. 2003; 4 (4): 21-25.
106. Zhang L, Morrison M, Nimmo GR, et al. Molecular investigation of bacterial communities on the inner and outer surfaces of peripheral venous catheters. Eur J Clin Microbiol Inf Dis. 2013; 32 (8): 1083-1090.
107. Mermel LA. What is the predominant source of intravascular catheter infections? Clin Infec Dis. 2011; 52 (2): 211-212.
108. Salzman MB, Isenberg HD, Shapiro JF, Lipsitz PJ, Rubin LG. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis. 1993; 167 (2): 487-490.
109. Ryder MA. Catheter related infections: it's all about biofilm. Top Adv Pract Nurs e-J. 2005; 5 (3): 1-15.
110. Jacobson AF, Winslow EH. Variables influencing intravenous catheter insertion difficulty and failure: an analysis of 339 intravenous catheter insertions. Heart Lung. 2005; 34 (5): 345-359.
111. Da Silva GA, Priebe S, Dias FN. Benefits of establishing an intravenous team and the standardization of peripheral intravenous catheters. J Infus Nurs. 2010; 33 (3): 156-160.
112. Kuensting LL, DeBoer S, Holleran R, Shultz BL, Steinmann RA, Venella J. Difficult venous access in children: taking control. J Emerg Nurs. 2009; 35 (5): 419-424.
113. Aponte H, Acosta S, Rigamonti D, Sylvia B, Austin P, Samolitis T. The use of ultrasound for placement of intravenous catheters. AANA J. 2007; 75 (3): 212-216.
114. Palefski SS, Stoddard GJ. The infusion nurse and patient complication rates of peripheral short catheters: a prospective evaluation. J Intraven Nurs. 2001; 24 (2): 113-122.
115. Hadaway L, Dalton L, Mercanti-Ereig L. Infusion teams in acute care hospitals: call for a business approach. J Infus Nurs. 2013; 36 (5): 356-360.
116. Boyd S, Aggarwal I, Davey P, Logan M, Nathwani D. Peripheral intravenous catheters: the road to quality improvement and safer patient care. J Hosp Infect. 2011; 77 (1): 37-41.
117. Moureau NL, Trick N, Nifong T, et al. Vessel health and preservation (part 1): a new evidence-based approach to vascular access selection and management. J Vasc Access. 2012; 13 (3): 351-356.
118. Fujita T, Namiki T, Suzuki T, Yamamoto E. Normal saline flushing for maintenance of peripheral intravenous sites. J Clin Nurs. 2006; 15 (1): 103-104.
119. Macklin D. IV catheter care and maintenance minimizes catheter-related blood stream infection. Cardiac Cath Lab Director. 2011; 1 (1): 20-24.
120. Vizcarra C, Cassutt C, Corbitt N, et al. Recommendations for improving safety practices with short peripheral catheters. J Infus Nurs. 2014; 37 (2): 121-124.
121. Moureau N, Dawson RB. Keeping needleless connectors clean, part 2. Nursing. 2010; 40 (6): 61-630.
122. Hadaway L. Needleless connectors: improving practice, reducing risks. JAVA. 2011; 16 (1): 20-33.
123. Timsit JF, DuBois Y, Minet C, et al. New materials and devices for preventing catheter-related infections. Ann Intensive Care. 2011; 1 (34): 1-9.
124. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis. 2002; 34 (9): 1232-1242.
125. Dougherty L. Peripheral cannulation. Nurs Stand. 2008; 22 (52): 49-56.
126. AccuCath [product brochure]. Naples, FL: Vascular Pathways; 2014.
127. Gorski LA, Hallock D, Kuehn SC, Morris P, Russell JM, Skala LC. Recommendations for frequency of assessment of the short peripheral catheter site. J Infus Nurs. 2012; 35 (5): 290-292.
128. Alkseyez S, Byrne M, Carpenter A, Franker C, Kidd C, Hulton L. Prolonging the life of a patient's IV: an integrative review of intravenous securement devices. Medsurg Nurs. 2012; 21 (5): 285-292.
129. Lopez-Lopez G, Pascual A, Perea EJ. Effect of plastic catheter material on bacterial adherence and viability. J Med Microbiol. 1991; 34 (6): 349-353.
130. Gaukroger PB, Roberts JG, Manners TA. Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Teflon cannulae in anaesthetic and postoperative use. Anaesth Intensive Care. 1998; 16 (3): 265-271.
131. Putnam Plastics. Considerations for introducers. Dayville, CT: Putnam Plastics; 2013.
132. SURFLO IV [product brochure]. Somerset, NJ: Terumo Medical Products; 2014.
133. Houston PA. Obtaining vascular access in the obese patient population. J Infus Nurs. 2013; 36 (1): 52-56.
134. Nafiu OO, Burke C, Cowan A, Tutuo N, Maclean S, Tremper KK. Comparing peripheral venous access between obese and normal weight children. Paediatr Anaesth. 2010; 20 (2): 172-176.
135. Kristiniak S, Harpel J, Breckenridge DM, Buckle J. Black pepper essential oil to enhance intravenous catheter insertion in patients with poor vein visibility: a controlled study. J Altern Complement Med. 2012; 18 (11): 1003-1007.
136. Kule A, Hang B, Bahl A. Preventing the collapse of a peripheral vein during cannulation: an evaluation of various tourniquet techniques on vein compressibility. J Emerg Med. 2014; 46 (5): 659-666.
137. De Negri DC, Avelar AF, Andreoni S, Pedreira Mda L. Predisposing factors for peripheral intravenous puncture failure in children. Rev Lat Am Enfermagem. 2012; 20 (6): 1072-1080.
138. Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA. 1994; 271 (13): 1014-1016.
139. Btaiche IF, Kovacevich DS, Khalidi N, Papke LF. The effects of needleless connectors on catheter-related thrombotic occlusions. J Infus Nurs. 2011; 34 (2): 89-95.
140. Campbell H, Carrington M. Peripheral IV cannula dressings: advantages and disadvantages. Br J Nurs. 1999; 8 (21): 1420-1427.
141. Cady M, Gross L, Lee N. IV tape: a potential vector for infection . Anesth Patient Safety Found Newsletter. Winter 2011; 1-3. http://www.apsf.org/newsletters/html/2011/winter/10-ivtape. htm. Accessed December 19, 2014.
142. Patel N, Smith CE, Pinchak AC, Hancock DE. Evaluation of different methods of securing intravenous catheters: measurement of forces during simulated accidental pullout. Can J Anaesth. 1995; 42 (6): 504-510.
143. Redelmeier DA, Livesley NJ. Adhesive tape and intravascularcatheter-associated infections. J Gen Intern Med. 1999; 14 (6): 373-375.
144. Hignell P. Peripheral intravenous initiation: self-learning module . Fraser Health Authority; 2012. http:www.fraserhealth.ca/media/PeripheralIntravenousInitiationModule.pdf. Accessed December 19, 2014.
145. Centers for Disease Control and Prevention. CDC/NHSN Surveillance Definitions for Specific Types of Infections. Atlanta, GA: Centers for Disease Control and Prevention; 2015. http://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef-current.pdf. Accessed December 19, 2014.
146. Tomlinson D, Mermel LA, Ethier MC, Matlow A, Gillmeister B, Sung L. Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review. Clin Infect Dis. 2011; 53 (7): 697-710.
147. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health-care associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008; 36 (5): 309-332.
148. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with non-cuffed short-term central venous catheters. Intensive Care Med. 2004; 30 (1): 62-67.
149. Segura M, Llado L, Guirao X, et al. A prospective study of a new protocol for in-situ diagnosis of central venous catheter related bacteremia. Clin Nutr. 1993; 12 (2): 103-107.
150. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002; 136 (11): 792-781.
151. Brown E, Wenzel RP, Hendley JO. Exploration of the microbial anatomy of the normal human skin by using plasmid profiles of coagulase-negative staphylococci: search for the reservoir of resident skin flora. J Infect Dis. 1989; 160 (4): 644-650.
152. Hendley JO, Ashe KM. Effect of topical antimicrobial treatment on aerobic bacteria in the stratum corneum of human skin. Antimicrob Agents Chemother. 1991; 35 (4): 627-631.
153. Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest. 2003; 112 (1): 1466-1477.
154. Jarvis WR, Murphy C, Hall KK, et al. Health care-associated bloodstream infections associated with negative-or positivepressure or displacement mechanical valve needleless connectors . Clin Infect Dis. 2009; 49 (12): 1821-1827.
155. Karchmer TB, Cook EM, Palavecino E, Ohl C, Sheretz R. Needleless valve ports may be associated with a high rate of catheter-related bloodstream infection [abstract]. Abstract in: Program of the 15th Annual Meeting of the Society for Healthcare Epidemiology of America. April 9-12, 2005; Los Angeles, CA.
156. Kaler W, Chinn R. Successful disinfection of needleless access ports: a matter of time and friction. J Assoc Vasc Access. 2007; 12 (3): 140-147.
157. Hadaway L. Hub disinfection and its impact on catheter-related infections. J Vasc Access Devices. 2001; 6 (2): 33-36.
158. Institute for Healthcare Improvement. Scrub the hub: example posters. http://www.ihi.org/resources/Pages/Tools/ScrubtheHub Posters.aspx. Accessed July 21, 2014.
159. Hatler C, Hebden J, Kaler W, et al. Walk the walk to reduce catheter-related bloodstream infections. Am Nurse Today. 2010; 5 (1): 26-30.
160. Donlan RM. Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner. Clin Infect Dis. 2011; 52 (8): 1038-1045.
161. Perisamy S, Joo HS, Duong AC, et al. How Staphylococcus aureus biofilms develop their characteristic structure. Proc Natl Acad Sci USA. 2012; 109 (4): 1281-1286.
162. Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001; 7 (2): 277-281.
163. Raad I. Intravascular-catheter-related infections. Lancet. 1998; 351 (9106): 893-898.
164. Van Rooden CJ, Schippers EF, Barge RM, et al. Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol. 2005; 23 (12): 2655-2660.